Expert Process Development

Based on our best-view platform, Veliter’s Process Development offers industry-leading development services to solutions tailored to individual customer needs, from the lab to validation and commercial manufacture. Our experts team will ensure our approaches are aligned with regulatory guidelines and GMP industry best practices.

Experience makes  the difference

Veliter’s development and scale-up experience covers various therapeutic oligonucleotide modifications (special nucleotides, PS/PN replacement of PO, chemical modification on 2’ position of nucleotides, 2’-4’ locked nucleotides, chemical modification on phosphorus, conjugated oligonucleotides,etc) in the market. Our technical team constantly explores and brings you emerging chemical modifications and processes.

Commercial offer

Veliter is capable of supporting you with commercial oligonucleotides and beyond.

Process development capabilities:

  • Synthesis, cleavage and de-protection, purification, and downstream processing of various complex and modified DNA, RNA and analogue oligonucleotides
  • Pre-clinical non-GMP and GMP-like oligo production
  • Process parameter screening and robustness testing using Design of Experiments
  • PS, PO, PN and mixed backbone sequences
  • Conjugation including GalNAc,PEG and analogues etc.
  • Sequences from <10 to <150 bases
  • Process Performance Qualification activities and support

Positive oligo program experience, from end to end

Focusing on your needs and building long-term partnerships, your own Veliter’s project manager will be flexible and responsive. This is Veliter’s approach to make your oligonucleotide program move smoothly through pre-clinical to commercial.

Products & Services

Our Awards

Globe-Awards
Globe-Awards (2)
Globe-Awards (3)
Globe-Awards (2)
Globe-Awards (3)
Globe-Awards
Globe-Awards (1)
Globe-Awards (4)
Globe-Awards (1)
Globe-Awards (2)
Globe-Awards (2)